LAURA KATHLEEN HUMMERS

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology BALTIMORE, MD NPI 1104879527

General Payments — all program years on this page

$70,584.76

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $21,719.68 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $20,605.004
Travel and Lodging $745.602
Food and Beverage $369.084

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $16,110.001
Boehringer Ingelheim Pharmaceuticals, Inc. $2,453.852
ABBVIE INC. $2,225.903
AstraZeneca UK Limited $929.934

By program year

Program yearAmountRecords
2018 $2,400.001
2019 $29,740.4038
2020 $2,887.095
2021 $3,848.626
2022 $4,712.502
2023 $5,276.4717
2024 $21,719.6810

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093885297 AstraZeneca UK Limited $134.98 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093946883 AstraZeneca UK Limited $517.60 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093960410 AstraZeneca UK Limited $49.35 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094030872 AstraZeneca UK Limited $228.00 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1103135459 ABBVIE INC. $600.00 10/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103135461 ABBVIE INC. $1,575.00 12/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103954200 ABBVIE INC. $50.90 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105543535 AstraZeneca Pharmaceuticals LP $16,110.00 07/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117875295 Boehringer Ingelheim Pharmaceuticals, Inc. $133.85 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117875297 Boehringer Ingelheim Pharmaceuticals, Inc. $2,320.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.